Barbara Ann Karmanos Cancer Institute

This study is testing if adding a new drug called selinexor to the standard chemotherapy regimen (RCHOP) is safe and more effective for treating B-cell non-Hodgkin's lymphoma. It will first find the safest dose of the combination, then see how well it works for newly diagnosed pa…

This study is testing whether adding a new targeted drug called polatuzumab vedotin to standard chemotherapy works better for people with aggressive types of B-cell lymphoma. The trial aims to see if this combination helps more patients achieve complete remission and controls the…